Back to top
more

Evolent Health (EVH)

(Delayed Data from NYSE)

$27.65 USD

27.65
1,055,481

-0.67 (-2.37%)

Updated Apr 26, 2024 04:00 PM ET

After-Market: $27.65 0.00 (0.00%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.20%
2Buy18.04%
3Hold9.52%
4Sell5.20%
5Strong Sell2.60%
S&P50011.13%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

C Value A Growth A Momentum A VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 26% (65 out of 252)

Industry: Internet - Software

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Balance Sheet

Research for EVH

The Zacks Equity Research reports, or ZER for short, are our in-house, independently produced research reports.

The ever popular one-page Snapshot reports are generated for virtually every single Zacks Ranked stock. It's packed with all of the company's key stats and salient decision making information. Including the Zacks Rank, Zacks Industry Rank, Style Scores, the Price, Consensus & Surprise chart, graphical estimate analysis and how a stocks stacks up to its peers.

The detailed multi-page Analyst report does an even deeper dive on the company's vital statistics. In addition to all of the proprietary analysis in the Snapshot, the report also visually displays the four components of the Zacks Rank (Agreement, Magnitude, Upside and Surprise); provides a comprehensive overview of the company business drivers, complete with earnings and sales charts; a recap of their last earnings report; and a bulleted list of reasons to buy or sell the stock. It also includes an industry comparison table to see how your stock compares to its expanded industry, and the S&P 500.

Researching stocks has never been so easy or insightful as with the ZER Analyst and Snapshot reports.

Learn more about Zacks Equity Research reports

See more Zacks Equity Research reports

 

Fiscal Year End for Evolent Health, Inc falls in the month of December.

All items in Millions except Per Share data.

12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019
Assets          
Cash & Equivalents 207 203 342 359 123
Receivables 447 255 131 126 76
Notes Receivable 0 0 0 0 0
Inventories 0 0 0 0 0
Other Current Assets 30 21 51 61 30
Total Current Assets 684 478 524 546 229
Net Property & Equipment 78 88 81 86 85
Investments & Advances 22 17 18 25 148
Other Non-Current Assets 0 0 0 0 0
Deferred Charges 0 0 0 0 0
Intangibles 1,869 1,166 706 623 881
Deposits & Other Assets 16 20 39 33 84
Total Assets 2,680 1,817 1,419 1,370 1,498
Liabilities & Shareholders Equity 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019
Notes Payable 0 0 0 27 0
Accounts Payable 48 57 96 32 37
Current Portion Long-Term Debt 0 0 0 0 0
Current Portion Capital Leases 0 0 0 0 0
Accrued Expenses 206 164 159 133 68
Income Taxes Payable 0 0 0 0 0
Other Current Liabilities 410 205 183 203 81
Total Current Liabilities 674 433 445 402 193
Mortgages 0 0 0 0 0
Deferred Taxes/Income 13 5 1 1 2
Convertible Debt 0 0 0 0 0
Long-Term Debt 597 413 216 263 294
Non-Current Capital Leases 0 0 0 0 0
Other Non-Current Liabilities 112 51 6 22 12
Minority Interest (Liabilities) 0 0 0 0 0
Total Liabilities 1,434 958 726 751 569
Shareholders Equity 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019
Preferred Stock 178 0 0 0 0
Common Stock (Par) 1 1 1 1 1
Capital Surplus 1,808 1,487 1,341 1,229 1,174
Retained Earnings -719 -606 -627 -589 -252
Other Equity -1 -1 0 0 6
Treasury Stock 21 21 21 21 0
Total Shareholder's Equity 1,246 859 694 620 929
Total Liabilities & Shareholder's Equity 2,680 1,817 1,419 1,370 1,498
Total Common Equity 1,068 859 694 620 929
Shares Outstanding 113.80 99.90 89.20 84.30 84.50
Book Value Per Share 9.38 8.60 7.78 7.35 10.99

Fiscal Year End for Evolent Health, Inc falls in the month of December.

All items in Millions except Per Share data.

3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023
Assets          
Cash & Equivalents -99,999 207 208 190 179
Receivables NA 447 394 345 263
Notes Receivable NA 0 0 0 0
Inventories NA 0 0 0 0
Other Current Assets NA 30 37 41 34
Total Current Assets NA 684 639 577 476
Net Property & Equipment NA 78 80 84 89
Investments & Advances NA 22 22 22 17
Other Non-Current Assets NA 0 0 0 0
Deferred Charges NA 0 0 0 0
Intangibles NA 1,869 1,895 1,919 1,944
Deposits & Other Assets NA 16 17 18 20
Total Assets NA 2,680 2,670 2,647 2,589
Liabilities & Shareholders Equity 3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023
Notes Payable NA 0 1 0 0
Accounts Payable NA 48 52 77 51
Current Portion Long-Term Debt NA 0 0 0 0
Current Portion Capital Leases NA 0 0 0 0
Accrued Expenses NA 206 244 205 198
Income Taxes Payable NA 0 0 0 0
Other Current Liabilities NA 410 306 253 204
Total Current Liabilities NA 674 615 541 458
Mortgages NA 0 0 0 0
Deferred Taxes/Income NA 13 27 34 36
Convertible Debt NA 0 0 0 0
Long-Term Debt NA 597 600 633 632
Non-Current Capital Leases NA 0 0 0 0
Other Non-Current Liabilities NA 116 116 117
Minority Interest (Liabilities) NA 0 0 0 0
Total Liabilities NA 1,434 1,398 1,381 1,297
Shareholders Equity 3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023
Preferred Stock NA 178 176 173 171
Common Stock (Par) NA 1 1 1 1
Capital Surplus NA 1,808 1,803 1,775 1,769
Retained Earnings NA -719 -686 -660 -626
Other Equity NA -1 -1 -1 -1
Treasury Stock NA 21 21 21 21
Total Shareholder's Equity NA 1,246 1,272 1,266 1,292
Total Liabilities & Shareholder's Equity NA 2,680 2,670 2,647 2,589
Total Common Equity 0 1,068 1,096 1,093 1,122
Shares Outstanding 115.40 113.80 114.90 113.20 112.60
Book Value Per Share 0.00 9.38 9.54 9.66 9.96